UK Markets open in 1 hr 41 mins

Neurocrine Biosciences, Inc. (0K6R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
97.29-1.11 (-1.13%)
At close: 06:05PM BST
Full screen
Previous close98.40
Bid0.00 x 0
Ask0.00 x 0
Day's range97.29 - 97.61
52-week range97.29 - 97.61
Avg. volumeN/A
Market cap9.575B
Beta (5Y monthly)0.70
PE ratio (TTM)21.42
EPS (TTM)4.54
Earnings date02 Feb 2022 - 07 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript

    With me as usual are Kevin Gorman, our chief executive officer; Matt Abernethy, our chief financial officer; Eiry Roberts, our chief medical officer; Eric Benevich, our chief commercial officer; and Kyle Gano, our chief business development and strategy officer. Before we get going, I'll remind everyone that during today's call, we will be making forward-looking statements.

  • Zacks

    Neurocrine Biosciences (NBIX) Lags Q1 Earnings Estimates

    Neurocrine (NBIX) delivered earnings and revenue surprises of -57.58% and 1.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Simply Wall St.

    Is Neurocrine Biosciences (NASDAQ:NBIX) A Risky Investment?

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...